✦ LIBER ✦

S1035 Certolizumab Pegol is Effective at Maintaining Response and Remission in Patients With Fistulising Crohn's Disease: 3-Year Results From the PRECiSE 3 Study

✍ Scribed by Stefan Schreiber; Ian C. Lawrance; Ole O. Thomsen; Stephen B. Hanauer; Ralph Bloomfield; William J. Sandborn

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

S1030 Predictors of Response and Remissi

✍ William J. Sandborn; Maria T. Abreu; Geert R. D'Haens; Jean-Frederic Colombel; S 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 142 KB

S1037 Certolizumab Pegol Demonstrates Ef

✍ Stefan Schreiber; Munaa Khaliq-Kareemi; Ian C. Lawrance; Ole O. Thomsen; Stephen 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Long-Term Remission With Certolizumab Pe

✍ Sandborn, William J. ;Schwartz, David A. ;Schreiber, Stefan ;Lawrance, Ian C. ;S 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 463 KB

S1040 Long-Term Remission With Certolizu

✍ Gary Lichtenstein; Ole O. Thomsen; Stefan Schreiber; Ian C. Lawrance; Stephen B. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 80 KB

P066 ANALYSIS OF THE EFFECT OF INDUCTION

✍ G. D'Haens; K. Mitchev; W. Sandborn 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 75 KB

S1064 Certolizumab Pegol Effectiveness i

✍ Maria T. Abreu; Severine Vermeire; Paul J. Rutgeerts; Thomas A. Ullman; Douglas 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 100 KB